{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:39:11Z","timestamp":1784086751324,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":404,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jacep.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T17:36:20Z","timestamp":1463592980000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Increased Incidence of Ventricular\u00a0Arrhythmias in Patients With\u00a0Advanced\u00a0Cancer and Implantable\u00a0Cardioverter-Defibrillators"],"prefix":"10.1016","volume":"3","author":[{"given":"Andr\u00e9s","family":"Enriquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Biagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Redfearn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Boles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariha Sadiq","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma M.","family":"Hopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoshiar","family":"Abdollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Baranchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2016.03.001_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2016.03.001_bib2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.RES.0000145047.14691.db","article-title":"What causes sudden death in heart failure?","volume":"95","author":"Tomaselli","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2016.03.001_bib3","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2016.03.001_bib4","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1200\/JCO.2003.10.009","article-title":"Effect of arsenic trioxide on QT interval in patients with advanced malignancies","volume":"21","author":"Barbey","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacep.2016.03.001_bib5","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-03-080689","article-title":"Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance","volume":"110","author":"Kantarjian","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jacep.2016.03.001_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(05)70093-0","article-title":"Cardiac tumours: diagnosis and management","volume":"6","author":"Butany","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jacep.2016.03.001_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/annonc\/mdh086","article-title":"Metastases to the heart","volume":"15","author":"Reynen","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jacep.2016.03.001_bib8","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1161\/01.CIR.92.11.3255","article-title":"Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group","volume":"92","author":"Kowey","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2016.03.001_bib9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1540-8167.2004.04352.x","article-title":"Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm","volume":"15","author":"Verma","year":"2004","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2016.03.001_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1542-474X.2007.00187.x","article-title":"Electrical storm in patients with an implanted defibrillator: a matter of definition","volume":"12","author":"Israel","year":"2007","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.jacep.2016.03.001_bib11","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.hrthm.2013.01.035","article-title":"The National ICD Registry report: version 2.1 including leads and pediatrics for years 2010 and 2011","volume":"10","author":"Kremers","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2016.03.001_bib12","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/europace\/euv076","article-title":"Implantable cardioverter-defibrillators and subsequent cancer risk: a nationwide population-based cohort study","volume":"17","author":"Pedersen","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2016.03.001_bib13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jacep.2016.03.001_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mrrev.2008.03.002","article-title":"Inflammation: gearing the journey to cancer","volume":"659","author":"Kundu","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.jacep.2016.03.001_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cyto.2009.06.003","article-title":"Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm","volume":"47","author":"Streitner","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.jacep.2016.03.001_bib16","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/01.CIR.0000017493.03108.1C","article-title":"Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death","volume":"105","author":"Albert","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2016.03.001_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2009.06.014","article-title":"Sudden death: do cytokines and prothrombotic peptides contribute to the occurrence of ventricular fibrillation during acute myocardial infarction?","volume":"145","author":"Elmas","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2016.03.001_bib18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/clc.4960140814","article-title":"Life-threatening ventricular tachycardia as the presenting symptom of metastatic cardiac disease","volume":"14","author":"Mager","year":"1991","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacep.2016.03.001_bib19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1378\/chest.99.5.1296","article-title":"Metastatic melanoma to the heart presenting with ventricular tachycardia","volume":"99","author":"Sheldon","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.jacep.2016.03.001_bib20","first-page":"890","article-title":"Metastatic melanoma presenting as polymorphic ventricular tachycardia","volume":"39","author":"Sharma","year":"2012","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.jacep.2016.03.001_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jcp.2005.035105","article-title":"Cardiac metastases","volume":"60","author":"Bussani","year":"2007","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jacep.2016.03.001_bib22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jacc.2004.06.032","article-title":"Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the World Trade Center attack","volume":"44","author":"Steinberg","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2016.03.001_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/01.CIR.101.2.158","article-title":"Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverter-defibrillators","volume":"101","author":"Lampert","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2016.03.001_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/hc0502.103330","article-title":"Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks","volume":"105","author":"Schron","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2016.03.001_bib25","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.hrthm.2010.04.033","article-title":"HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy","volume":"7","author":"Lampert","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2016.03.001_bib26","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/pace.12188","article-title":"End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy","volume":"36","author":"Sherazi","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"issue":"Suppl 1","key":"10.1016\/j.jacep.2016.03.001_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11606-007-0239-8","article-title":"\u201cThat's like an act of suicide\u201d patients' attitudes toward deactivation of implantable defibrillators","volume":"23","author":"Goldstein","year":"2008","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacep.2016.03.001_bib28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1540-8159.2012.03359.x","article-title":"The use of advance directives among patients with\u00a0implantable cardioverter defibrillators","volume":"35","author":"Tajouri","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2016.03.001_bib29","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.hrthm.2010.07.018","article-title":"Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment","volume":"7","author":"Kramer","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2016.03.001_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jacc.2009.04.030","article-title":"Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians","volume":"54","author":"Goldstein","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X16300147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X16300147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:23:07Z","timestamp":1762500187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X16300147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S2405500X16300147"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2016.03.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732536159.793541842","asserted-by":"object"}]},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Incidence of Ventricular\u00a0Arrhythmias in Patients With\u00a0Advanced\u00a0Cancer and Implantable\u00a0Cardioverter-Defibrillators","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier","name":"copyright","label":"Copyright"}]}}